Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase

Molecular and Cellular Biology

Volumn 21, Issue 12, 2001, Pages 4016-4031

  Lu, Zhimin ^a   Jiang, Guoqiang ^a   Blume Jensen, Peter ^a   Hunter, Tony ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; FIBRONECTIN; FOCAL ADHESION KINASE; PAXILLIN; PROTEIN TYROSINE KINASE INHIBITOR; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CANCER INVASION; CELL ADHESION; CELL MOTILITY; CELL SPREADING; CELL STRUCTURE; DEPHOSPHORYLATION; ENZYME ACTIVITY; ENZYME BINDING; ENZYME LOCALIZATION; ENZYME MODIFICATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL;

3T3 CELLS; ALU ELEMENTS; ANIMALS; BASE SEQUENCE; CELL ADHESION; CELL MOVEMENT; CYTOSKELETAL PROTEINS; DNA PRIMERS; DOWN-REGULATION; EPIDERMAL GROWTH FACTOR; FOCAL ADHESION KINASE 1; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PAXILLIN; PHENOTYPE; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETINOBLASTOMA-LIKE PROTEIN P130; TUMOR CELLS, CULTURED;

ANIMALIA; MUS MUSCULUS;

EID: 0035018353     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.21.12.4016-4031.2001     Document Type: Article

References (81)

1. Angers-Loustau, A., J. F. Cote, A. Charest, D. Dowbenko, S. Spencer, L. A. Lasky, and M. L. Tremblay. 1999. Protein tyrosine phosphatase-PEST regulates focal adhesion disassembly, migration, and cytokinesis in fibroblasts. J. Cell. Biol. 144:1019-1031.
2. Arcaro, A., M. J. Zvelebil, C. Wallasch, A. Ullrich, M. D. Waterfield, and J. Domin. 2000. Class II phosphoinositide 3-kinases are downstream targets of activated polypeptide growth factor receptors. Mol. Cell. Biol. 20:3817-3830.
3. Barnes, D. W. 1982. Epidermal growth factor inhibits growth of A431 human epidermoid carcinoma in serum-free cell culture. J. Cell. Biol. 93:1-4.
4. Berger, M. S., C. Greenfield, W. J. Gullick, J. Haley, J. Downward, D. E. Neal, A. L. Harris, and M. D. Waterfield. 1987. Evaluation of epidermal growth factor receptors in bladder tumours. Br. J. Cancer 56:533-537.
5. Birchmeier, W., K. M. Weidner, and J. Behrens. 1993. Molecular mechanisms leading to loss of differentiation and gain of invasiveness in epithelial cells. J. Cell Sci. Suppl. 17:159-164.
6. Burridge, K., C. E. Turner, and L. H. Romer. 1992. Tyrosine phosphorylation of paxillin and pp125FAK accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly. J. Cell. Biol. 119:893-903.
7. Calalb, M. B., T. R. Polte, and S. K. Hanks. 1995. Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases. Mol. Cell. Biol. 15:954-963.
8. Cary, L. A., J. F. Chang, and J. L. Guan. 1996. Stimulation of cell migration by overexpression of focal adhesion kinase and its association with Src and Fyn. J. Cell Sci. 109:1787-1794.
9. Cary, L. A., D. C. Han, T. R. Polte, S. K. Hanks, and J. L. Guan. 1998. Identification of p130Cas as a mediator of focal adhesion kinase-promoted cell migration. J. Cell. Biol. 140:211-221.
10. Chen, H. C., P. A. Appeddu, H. Isoda, and J. L. Guan. 1996. Phosphorylation of tyrosine 397 in focal adhesion kinase is required for binding phosphatidylinositol 3-kinase. J. Biol. Chem. 271:26329-26334.
11. Chen, H. C., P. A. Appeddu, J. T. Parsons, J. D. Hildebrand, M. D. Schaller, and J. L. Guan. 1995. Interaction of focal adhesion kinase with cytoskeletal protein talin. J. Biol. Chem. 270:16995-16999.
12. Chinkers, M., J. A. McKanna, and S. Cohen. 1981. Rapid rounding of human epidermoid carcinoma cells A-431 induced by epidermal growth factor. J. Cell. Biol. 88:422-429.
13. Danjo, Y., and I. K. Gipson. 1998. Actin 'purse string' filaments are anchored by E-cadherin-mediated adherens junctions at the leading edge of the epithelial wound, providing coordinated cell movement. J. Cell Sci. 111:3323-3332.
14. Ethier, S. P., B. C. Langton, and C. A. Dilts. 1996. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha. Mol. Carcinog. 15:134-143.
15. Friedl, P., K. S. Zanker, and E. B. Brocker. 1998. Cell migration strategies in 3-D extracellular matrix: differences in morphology, cell matrix interactions, and integrin function. Microsc. Res. Technol. 43:369-378.
16. Garton, A. J., and N. K. Tonks. 1999. Regulation of fibroblast motility by the protein tyrosine phosphatase PTP-PEST. J. Biol. Chem. 274:3811-3818.
17. Ginsburg, E., and B. K. Vonderhaar. 1985. Epidermal growth factor stimulates the growth of A431 tumors in athymic mice. Cancer Lett. 28:143-150.
18. Guan, J. L., and D. Shalloway. 1992. Regulation of focal adhesion-associated protein tyrosine kinase by both cellular adhesion and oncogenic transformation. Nature 358:690-692.
19. Guinebault, C., B. Payrastre, C. Racaud-Sultan, H. Mazarguil, M. Breton, G. Mauco, M. Plantavid, and H. Chap. 1995. Integrin-dependent translocation of phosphoinositide 3-kinase to the cytoskeleton of thrombin-activated platelets involves specific interactions of p85 alpha with actin filaments and focal adhesion kinase. J. Cell. Biol. 129:831-842.
20. Gullick, W. J. 1991. Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers. Br. Med. Bull. 47:87-98.
21. Guvakova, M. A., and E. Surmacz. 1999. The activated insulin-like growth factor I receptor induces depolarization in breast epithelial cells characterized by actin filament disassembly and tyrosine dephosphorylation of FAK. Cas, and paxillin. Exp. Cell Res. 251:244-255.
22. Harte, M. T., J. D. Hildebrand, M. R. Burnham, A. H. Bouton, and J. T. Parsons. 1996. p130Cas, a substrate associated with v-Src and v-Crk, localizes to focal adhesions and binds to focal adhesion kinase. J. Biol. Chem. 271:13649-13655.
23. Hassid, A., S. Huang, and J. Yao. 1999. Role of PTP-1B in aortic smooth muscle cell motility and tyrosine phosphorylation of focal adhesion proteins. Am. J. Physiol. 277:H192-H198.
24. Hauck, C. R., D. A. Hsia, and D. D. Schlaepfer. 2000. Focal adhesion kinase facilitates platelet-derived growth factor-BB-stimulated ERK2 activation required for chemotaxis migration of vascular smooth muscle cells. J. Biol. Chem. 275:41092-41099.
25. Hildebrand, J. D., M. D. Schaller, and J. T. Parsons. 1995. Paxillin, a tyrosine phosphorylated focal adhesion-associated protein binds to the carboxyl terminal domain of focal adhesion kinase. Mol. Biol. Cell 6:637-647.
26. Hildebrand, J. D., J. M. Taylor, and J. T. Parsons. 1996. An SH3 domain-containing GTPase-activating protein for Rho and Cdc42 associates with focal adhesion kinase. Mol. Cell. Biol. 16:3169-3178.
27. Huttenlocher, A., M. Lakonishok, M. Kinder, S. Wu, T. Truong, K. A. Knudsen, and A. F. Horwitz. 1998. Integrin and cadherin synergy regulates contact inhibition of migration and motile activity. J. Cell. Biol. 141:515-526.
28. Ilic, D., Y. Furuta, S. Kanazawa, N. Takeda, K. Sobue, N. Nakatsuji, S. Nomura, J. Fujimoto, M. Okada, and T. Yamamoto. 1995. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 377:539-544.
29. Karni, R., and A. Levitzki. 2000. pp60(cSrc) is a caspase-3 substrate and is essential for the transformed phenotype of A431 cells. Mol. Cell. Biol. Res. Commun. 3:98-104.
30. Kawamoto, T., J. D. Sato, A. Le, J. Polikoff, G. H. Sato, and J. Mendelsohn. 1983. Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody. Proc. Natl. Acad. Sci. USA 80:1337-1341.
31. Kim, H. G., J. Kassis, J. C. Souto, T. Turner, and A. Wells. 1999. EGF receptor signaling in prostate morphogenesis and tumorigenesis. Histol. Histopathol. 14:1175-1182.
32. Kim, J., W. Yu, K. Kovalski, and L. Ossowski. 1998. Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay. Cell 94:353-362.
33. Klemke, R. L., S. Cai, A. L. Giannini, P. J. Gallagher, P. de Lanerolle, and D. A. Cheresh. 1997. Regulation of cell motility by mitogen-activated protein kinase. J. Cell. Biol. 137:481-492.
34. Klemke, R. L., J. Leng, R. Molander, P. C. Brooks, K. Vuori, and D. A. Cheresh. 1998. CAS/Crk coupling serves as a "molecular switch" for induction of cell migration. J. Cell. Biol. 140:961-972.
35. Kogan, S. C., M. Doherty, and J. Gitschier. 1987. An improved method for prenatal diagnosis of genetic diseases by analysis of amplified DNA sequences: application to hemophilia A. N. Engl. J. Med. 317:985-990.
36. Kornberg, L., H. S. Earp, J. T. Parsons, M. Schaller, and R. L. Juliano. 1992. Cell adhesion or integrin clustering increases phosphorylation of a focal adhesion-associated tyrosine kinase. J. Biol. Chem. 267:23439-23442.
37. Kumar, R., and J. Mendelsohn. 1990. Growth regulation of A431 cells. Modulation of expression of transforming growth factor-alpha mRNA and 2′,5′-oligoadenylate synthetase activity. J. Biol. Chem. 265:4578-4582.
38. Lauffenburger, D. A., and A. F. Horwitz. 1996. Cell migration: a physically integrated molecular process. Cell 84:359-369.
39. Lemoine, N. R., C. M. Hughes, W. J. Gullick, C. L. Brown, and D. Wynford-Thomas. 1991. Abnormalities of the EGF receptor system in human thyroid neoplasia. Int. J. Cancer 49:558-561.
40. Libermann, T. A., H. R. Nusbaum, N. Razon, R. Kris. I. Lax, H. Soreq, N. Whittle, M. D. Waterfield, A. Ullrich, and J. Schlessinger. 1985. Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature 313:144-147.
41. neu Mol. Carcinog. 25:150-154.
42. Lu, Z., A. Hornia, Y. W. Jiang, Q. Zang, S. Ohno, and D. A. Foster. 1997. Tumor promotion by depleting cells of protein kinase C delta. Mol. Cell. Biol. 17:3418-3428.
43. Ma, L., C. Gauville, Y. Berthois, A. Degeorges, G. Millot, P. M. Martin, and F. Calvo. 1998. Role of epidermal-growth-factor receptor in tumor progression in transformed human mammary epithelial cells. Int. J. Cancer 78:112-119.
44. Maher, P. A. 1993. Activation of phosphotyrosine phosphatase activity by reduction of cell-substrate adhesion. Proc. Natl. Acad. Sci. USA 90:11177-11181.
45. Manes, S., E. Mira, C. Gomez-Mouton, Z. J. Zhao, R. A. Lacalle, and A. C. Martinez. 1999. Concerted activity of tyrosine phosphatase SHP-2 and focal adhesion kinase in regulation of cell motility. Mol. Cell. Biol. 19:3125-3135.
46. Matsumoto, K., B. L. Ziober, C. C. Yao, and R. H. Kramer. 1995. Growth factor regulation of integrin-mediated cell motility. Cancer Metastasis Rev. 14:205-217.
47. Maung, K., D. J. Easty, S. P. Hill, and D. C. Bennett. 1999. Requirement for focal adhesion kinase in tumor cell adhesion. Oncogene 18:6824-6828.
48. Miao, H., E. Burnett, M. Kinch, E. Simon, and B. Wang. 2000. Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation. Nat. Cell Biol. 2:62-69.
49. Mira, E., S. Manes, R. A. Lacalle, G. Marquez, and A. C. Martinez. 1999. Insulin-like growth factor I-triggered cell migration and invasion are mediated by matrix metalloproteinase-9. Endocrinology 140:1657-1664.
50. Nehls, V., and R. Herrmann. 1996. The configuration of fibrin clots determines capillary morphogenesis and endothelial cell migration. Microvasc. Res. 51:347-364.
51. Nelson, J. M., and D. W. Fry. 1997. Cytoskeletal and morphological changes associated with the specific suppression of the epidermal growth factor receptor tyrosine kinase activity in A431 human epidermoid carcinoma. Exp. Cell Res. 233:383-390.
52. Nolan, K., J. Lacoste, and J. T. Parsons. 1999. Regulated expression of focal adhesion kinase-related nonkinase, the autonomously expressed C-terminal domain of focal adhesion kinase. Mol. Cell. Biol. 19:6120-6129.
53. Owen, J. D., P. J. Ruest, D. W. Fry, and S. K. Hanks. 1999. Induced focal adhesion kinase (FAK) expression in FAK-null cells enhances cell spreading and migration requiring both auto-and activation loop phosphorylation sites and inhibits adhesion-dependent tyrosine phosphorylation of Pyk2. Mol. Cell. Biol. 19:4806-4818.
54. Owens, L. V., L. Xu, R. J. Craven, G. A. Dent, T. M. Weiner, L. Kornberg, E. T. Liu, and W. G. Cance. 1995. Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Res. 55:2752-2755.
55. Pasqualini, R., S. Bourdoulous, E. Koivunen, V. L. Woods, Jr., and E. Ruoslahti. 1996. A polymeric form of fibronectin has antimetastatic effects against multiple tumor types. Nat. Med. 2:1197-1203.
56. Polte, T. R., and S. K. Hanks. 1997. Complexes of focal adhesion kinase (FAK) and Crk-associated substrate (p130(Cas)) are elevated in cytoskeleton-associated fractions following adhesion and Src transformation. Requirements for Src kinase activity and FAK proline-rich motifs. J. Biol. Chem. 272:5501-5509.
57. Polte, T. R., and S. K. Hanks. 1995. Interaction between focal adhesion kinase and Crk-associated tyrosine kinase substrate p130Cas. Proc. Natl. Acad. Sci. USA 92:10678-10682.
58. Price, J. T., H. M. Wilson, and N. E. Haites. 1996. Epidermal growth factor (EGF) increases the in vitro invasion, motility and adhesion interactions of the primary renal carcinoma cell line, A704. Eur. J. Cancer 32A:1977-1982.
59. Retta, S. F., S. T. Barry, D. R. Critchley, P. Defilippi, L. Silengo, and G. Tarone. 1996. Focal adhesion and stress fiber formation is regulated by tyrosine phosphatase activity. Exp. Cell Res. 229:307-317.
60. Richardson, A., R. K. Malik, J. D. Hildebrand, and J. T. Parsons. 1997. Inhibition of cell spreading by expression of the C-terminal domain of focal adhesion kinase (FAK) is rescued by coexpression of Src or catalytically inactive FAK: a role for paxillin tyrosine phosphorylation. Mol. Cell. Biol. 17:6906-6914.
61. Richardson, A., and T. Parsons. 1996. A mechanism for regulation of the adhesion-associated proteintyrosine kinase pp125FAK. Nature 380:538-540. (Erratum, 381:810.)
62. Rosen, E. M., and I. D. Goldberg. 1989. Protein factors which regulate cell motility. In Vitro Cell Dev. Biol. 25:1079-1087.
63. Salomon, D. S., R. Brandt, F. Ciardiello, and N. Normanno. 1995. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit. Rev. Oncol. Hematol. 19:183-232.
64. Schlaepfer, D. D., S. K. Hanks, T. Hunter, and P. van der Geer. 1994. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature 372:786-791.
65. Schlaepfer, D. D., C. R. Hauck, and D. J. Sieg. 1999. Signaling through focal adhesion kinase. Prog. Biophys. Mol. Biol. 71:435-478.
66. Shibata, T., T. Kawano, H. Nagayasu, K. Okumura, M. Arisue, J. Hamada, N. Takeichi, and M. Hosokawa. 1996. Enhancing effects of epidermal growth factor on human squamous cell carcinoma motility and matrix degradation but not growth. Tumour Biol. 17:168-175.
67. Sieg, D. J., C. R. Hauck, D. Ilic, C. K. Klingbeil, E. Schaefer, C. H. Damsky, and D. D. Schlaepfer. 2000. FAK integrates growth-factor and integrin signals to promote cell migration. Nat. Cell Biol. 2:249-256.
68. Sieg, D. J., D. Ilic, K. C. Jones, C. H. Damsky, T. Hunter, and D. D. Schlaepfer. 1998. Pyk2 and Src-family protein-tyrosine kinases compensate for the loss of FAK in fibronectin-stimulated signaling events but Pyk2 does not fully function to enhance FAK-cell migration. EMBO J. 17:5933-5947.
69. Tachibana, K., T. Urano, H. Fujita, Y. Ohashi, K. Kamiguchi, S. Iwata, H. Hirai, and C. Morimoto. 1997. Tyrosine phosphorylation of Crk-associated substrates by focal adhesion kinase. A putative mechanism for the integrin-mediated tyrosine phosphorylation of Crk-associated substrates. J. Biol. Chem. 272:29083-29090.
70. Tamura, M., J. Gu, H. Tran, and K. M. Yamada. 1999. PTEN gene and integrin signaling in cancer. J. Natl. Cancer Inst. 91:1820-1828.
71. Tillotson, J. K., and D. P. Rose. 1991. Endogenous secretion of epidermal growth factor peptides stimulates growth of DU145 prostate cancer cells. Cancer Lett. 60:109-112.
72. Vande Woude, G. F., M. Jeffers, J. Cortner, G. Alvord, I. Tsarfaty, and J. Resau. 1997. Met-HGF/SF: tumorigenesis, invasion and metastasis. CIBA Found. Symp. 212:119-130.
73. Voldborg, B. R., L. Damstrup, M. Spang-Thomsen, and H. S. Poulsen. 1997. Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials. Ann. Oncol. 8:1197-1206.
74. Vuori, K., H. Hirai, S. Aizawa, and E. Ruoslahti. 1996. Introduction of p130cas signaling complex formation upon integrin-mediated cell adhesion: a role for Src family kinases. Mol. Cell. Biol. 16:2606-2613.
75. Wells, A. 2000. Tumor invasion: role of growth factor-induced cell motility. Adv. Cancer Res. 78:31-101.
76. Woodburn, J. R. 1999. The epidermal growth factor receptor and its inhibition in cancer therapy. Pharmacol. Ther. 82:241-250.
77. Xie, H., M. A. Pallero, K. Gupta, P. Chang, M. F. Ware, W. Witke, D. J. Kwiatkowski, D. A. Lauffenburger, J. E. Murphy-Ullrich, and A. Wells. 1998. EGF receptor regulation of cell motility: EGF induces disassembly of focal adhesions independently of the motilily-associated PLCgamma signaling pathway. J. Cell. Sci. 111:615-624.
78. Xie, H., T. Turner, M. H. Wang, R. K. Singh, G. P. Siegal, and A. Wells. 1995. In vitro invasiveness of DU-145 human prostate carcinoma cells is modulated by EGF receptor-mediated signals. Clin. Exp. Metastasis 13:407-419.
79. Xu, L. H., L. V. Owens, G. C. Sturge, X. Yang, E. T. Liu, R. J. Craven, and W. G. Cance. 1996. Attenuation of the expression of the focal adhesion kinase induces apoptosis in tumor cells. Cell Growth Differ. 7:413-418.
80. Yu, D. H., C. K. Qu, O. Henegariu, X. Lu, and G. S. Feng. 1998. Protein-tyrosine phosphatase Shp-2 regulates cell spreading, migration, and focal adhesion. J. Biol. Chem. 273:21125-21131.
81. Zheng, D. Q., A. S. Woodard, G. Tallini, and L. R. Languino. 2000. Substrate specificity of alpha vbeta 3 integrin-mediated cell migration and phosphatidylinositol 3-kinase/AKT pathway activation. J. Biol. Chem. 275: 24565-24574.